NSC |
Compound |
Enrichment |
Correlation |
NSC 687005 |
Null |
0.000184066440941432 |
0.44048492 |
NSC 330507 |
Tanespimycin |
0.00018474829680001 |
0.1966142 |
NSC 332421 |
1,3-Dioxolo[4,5-g]quinolin-8-amine, N-1,3-benzodioxol-5-yl-6-methyl- |
0.000216242727122389 |
0.37424226 |
NSC 36373 |
Naphtho[2,3-d]-1,3-dioxole-6,7-dimethanol, 5,6,7,8-tetrahydro-5-hydroxy-8-(3,4,5-trimethoxyphenyl)-, higher melting isomer |
0.000216242727122389 |
0.21370297 |
NSC 305802 |
2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- |
0.000281397700245213 |
0.43116022 |
NSC 365798 |
Fostamatinib disodium, Tamatinib fosdium |
0.000281397700245213 |
0.17181881 |
NSC 668490 |
Null |
0.000281397700245213 |
-0.087663502 |
NSC 720290 |
Methyl-7.alpha.,12.alpha.-Diacetoxy-5.beta.-cholan-24-oate-3 -spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane |
0.000285499812229894 |
0.28653621 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.000285499812229898 |
0.27634546 |
NSC 631583 |
Null |
0.000285499812229898 |
0.25398542 |